SCHEMBL741489

SCHEMBL741489

Cc1c(F)cccc1C1(O)CCC(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 19/20 0.46
HDAC9 Q9UKV0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12733562 0.85 HDAC4 (0.42) HDAC4
SCHEMBL2276508 0.79 SIGMAR1 (0.51) HDAC4HDAC9
SCHEMBL5371409 0.73 HDAC4 (0.48) HDAC4HDAC9
SCHEMBL8766307 0.70 HDAC4 (0.38) HDAC4
SCHEMBL27476922 0.70 HDAC4 (0.50) HDAC4HDAC9
SCHEMBL14063312 0.68 SLC6A3 (0.40)
SCHEMBL8817838 0.68 OPRL1 (0.50) HDAC4
SCHEMBL11920611 0.68 HPGD (0.39) HDAC4
SCHEMBL23231960 0.67 HDAC4 (0.50) HDAC4
SCHEMBL17316092 0.67 HDAC4 (0.45) HDAC4HDAC9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8137583-B2 Liquid crystal four-ring compound having fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-03-20 US disclosed
US-20110079753-A1 LIQUID CRYSTAL FOUR-RING COMPOUND HAVING FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110079753-A1 LIQUID CRYSTAL FOUR-RING COMPOUND HAVING FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE ROCK1, ROCK2, LEF1 HDAC4 2195/4885HDAC9 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.